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Abstract CRAMPED (CRM), conserved from plants to
animals, was previously characterized genetically as a
repressive factor involved in the formation of facultative
and constitutive heterochromatin (Polycomb silencing,
position effect variegation). We show that crm is dynam-
ically regulated during replication and identify the Histone
gene cluster (His-C) as a major CRM target. Surprisingly,
CRM is specifically required for the expression of the
Histone H1 gene, like the promoter-bound transcription
factor TRF2. Consistently with this, CRM genetically
interacts and co-immunoprecipitates with TRF2. However,
the Polycomb phenotypes observed in crm mutants are not
observed in TRF2 hypomorphic mutants, suggesting that
they correspond to independent roles of CRM. CRM is
thus a highly pleiotropic factor involved in both activation
and repression.
Introduction
Polycomb group proteins (PcG) constitute one of the best
characterized groups of chromatin regulators. These silenc-
ing factors, involved in the formation and the maintenance
of facultative heterochromatin, were initially identified
genetically in Drosophila by the homeotic phenotypes that
their mutations cause through the ectopic expression of hox
genes. However, genome-wide studies have subsequently
shown that hox genes represent only a small subset of PcG
targets (Schuettengruber et al. 2009). The products of most
Polycomb group genes have been shown to be components
of multimeric protein complexes with particular histone-
modifying activities (Klymenko et al. 2006; Nekrasov et al.
2005; Saurin et al. 2001; Schuettengruber and Cavalli 2009;
Simon and Kingston 2009). These complexes are highly
conserved between flies and mammals, some are even
present in plants (Birve et al. 2001; Levine et al. 2002).
Genetic screens have identified many genes that
positively or negatively interact with PcG genes. Posi-
tively interacting genes often encode members of PcG
complexes. However, particular factors identified geneti-
cally as PcG genes have not been identified in purified
PcG complexes, suggesting that they may interact only
transiently with PcG complexes members. For example,
super sex combs (sxc), encoding the glycosyltransferase
Ogt, may be particularly limiting for Polycomb silencing
because one of the Ogt targets is the PcG protein
Polyhomeotic (Gambetta et al. 2009). Even components
of PcG complexes can be also involved in PcG indepen-
dent processes. For example, the PcG protein Pho is also a
component of the chromatin remodeling complex, INO80,
involved in stress-induced transcription and DNA repair
(Klymenko et al. 2006). Genes negatively interacting with
PcG genes are called Trithorax group genes. Several genes
genes in different assays (Gildea et al. 2000). Thus, a new
functional category called enhancers of Trithorax and
Polycomb (ETP) has been established. Depending on
circumstances, these ETP are more limiting for activation
or repression (Salvaing et al. 2006).
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The Polycomb group protein CRAMPED is involved
with TRF2 in the activation of the histone H1 gene
initially categorized as PcG genes also function as TrxG
A few genes whose mutations genetically interact with
PcG genes are still not well characterized. One of these
genes is cramped (crm), a gene conserved from animals to
plants (Ehsan et al. 2004; Yamamoto et al. 1997). A
conserved MYB/SANT domain suggests that CRAMPED
(CRM) binds DNA or histone tails (Boyer et al. 2004; Ehsan
et al. 2004). Consistent with this, CRM can be detected on
Drosophila polytene chromosomes (Gibert et al. 2007;
Yamamoto et al. 1997). The crm mutant males die as
pharate or occasionally manage to hatch, but are very
weak. They have swollen aristae. In addition, they have
ectopic sex combs on posterior legs and on the second
tarsal segment of the first leg. The crm was therefore
classified as a PcG gene (Yamamoto et al. 1997).
However, CRM has not been found yet in any purified
Polycomb complexes (Klymenko et al. 2006; Nekrasov et
al. 2005; Saurin et al. 2001). Furthermore, crm mutants
show several phenotypes usually not typically observed in
PcG mutants (wing margin notches), suggesting that it
may function independently of the classic PcG proteins.
Here, we show that crm does indeed have PcG-
independent functions and is also involved in transcription
activation with the TATA binding protein (TBP)-related
factor 2 (TRF2), a component of core promoter recogni-
tion complexes.
Results
In vivo cytological characterization of CRM In order to
analyze the in vivo localization and dynamic of CRM, we
generated CRM fluorescent fusion proteins with the
fluorochromes EBFP2, mCherry or Venus (Ai et al. 2007;
Nagai et al. 2002; Shaner et al. 2004). The fusion constructs
were all integrated in the same genomic environment at 22A
with the PhiC31 transgenesis method (Bischof et al. 2007)
(with the exception of EBFP2-CRM inserted in 51D) and
were expressed under the control of the Gal4 upstream
activating sequence to allow conditional expression (Brand
and Perrimon 1993). To verify that our CRM–fluorophore
fusions are biologically active, we expressed them ubiqui-
tously (using a Gal4-expressing line under the control of the
tubulin promoter) and found that the fusion proteins
rescue crm mutant phenotypes giving rise to flies fully
viable and fertile. In vivo Venus–CRM chromosomal
binding was analyzed on salivary gland polytene chromo-
somes, using the weak and leaky expression of Gal4 from
the HS-Gal4 transgene in the absence of heat shock.
Observation of intact salivary glands gave two major
information. First, when compared to the level of RFP–
H2Av, it is visible that the level of Venus–CRM varies
across nuclei. (Fig. 1a, b, c). This is unlikely to be due to a
non-homogenous expression of HS-Gal4. Indeed, when
expressed under the control of Hs-Gal4 in salivary glands,
nuclear GFP is uniformly expressed unlike mCherry–
CRM (Supplementary Fig. 1). It might reflect posttran-
scriptional or posttranslational regulation of Venus–CRM.
Second, we distinctively observed a single bright band of
Venus–CRM in some of the nuclei where the general
nucleoplasmic signal is weaker (Fig. 1g–l). In many other
nuclei, we observe a high level of nucleoplasmic fluores-
cence that obfuscates discrete sites on the chromosomal
arms (Fig. 1d–f). Co-expression of a fluorescent fusion of
the histone H2Av shows that the band corresponds to a
with a fluorescent fusion of HP1 (Fig. 2a–c). Due to its
location and size, this bright band was reminiscent of the
histone gene cluster (His-C) (Liu et al. 2006). We
confirmed it by co-localization with a fluorescent fusion
of the histone cluster-specific marker, DLsm11 (Liu et al.
2006) (Fig. 2d–f).
Our observation in whole mount salivary glands
suggests that CRM is dynamically regulated. We ana-
lyzed CRM binding pattern on salivary gland polytene
chromosome spreads using antibodies directed against
CRM (Yamamoto et al. 1997). We observed that the
pattern was variable between individual chromosome
spreads. In order to assess whether it was due to technical
artifacts or correlated to a dynamic process such as
replication, we co-stained chromosomes with antibodies
against proliferating cell nuclear antigen (PCNA) (Fig. 3).
In the nuclei outside the S-phase (without PCNA stain-
ing), CRM is mostly detected on the histone locus and
more weakly in many bands across all chromosomes
(Fig. 3a). In the nuclei in the early S-phase (many PCNA
binding sites in euchromatic regions), most CRM signals
co-localize with PCNA, but CRM is present without
PCNA on His-C (Fig. 3b). Finally, in the nuclei in the
late S-phase (PCNA observed on the chromocenter), there
is much less co-localization of CRM and PCNA despite
the persistence of many PCNA bands, but both proteins
are enriched on the chromocenter (Fig. 3c). Note also the
persistence of CRM on His-C and more weakly on a few
sites (in particular some puffs) (Fig. 3c). Altogether, with
the pattern of Venus–CRM in whole mount salivary
glands, our observations indicate that CRM is always
present on His-C, and that in early S-phase, the CRM
protein co-localizes extensively with PCNA.
CRM regulates histone H1 transcription in salivary
gland The His-C is a complex made up of around 100
repeats ∼5 Kb in length, each containing single copies of
the transcription units for the linker histone (H1) and the
four core histones (H2A, H2B, H3, and H4). His-C is
known to be bound by the heterochromatic proteins HP1
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chromosome section (Fig. 1g–l). This band is located in
the nuclear periphery, near the chromocenter, visualized
and Su(var)3-9 (Ner et al. 2002; van Steensel and Henikoff
2000). His-C is repressed by Su(var)3-9, which is respon-
sible for the formation of compact heterochromatin at this
locus (Ner et al. 2002). As crm was previously character-
ized as a suppressor of variegation using the chromosomal
rearrangement wm4h (Yamamoto et al. 1997), CRM associ-
ation with the His-C suggested a role for CRM in the
establishment or the maintenance of repressive heterochro-
matin at the His-C.
In order to test this, we analyzed the expression levels of
the five histone genes (H1, H2A, H2B, H3, and H4) by real-
time PCR on wild-type or crm mutant salivary glands.
Surprisingly, we find that loss of crm has an effect on
histone gene activation rather than repression. In crm
mutants, the levels of H2A, H2B, H3, or H4 expression
remains unchanged, while the levels of H1 expression is
reduced 30 to 40 times (Fig. 4a; Student’s t test, p<0.05).
Western blot analysis of H1 protein level in wild-type (WT)
Fig. 1 In vivo imaging of CRM
fluorescent protein fusions. a–c
Whole mount third larval instar
salivary gland showing Venus–
CRM (green; a, c) and RFP–
H2Av (red; b, c). d–l Individual
salivary gland nuclei with
mRFP–H2Av (red) and different
level of Venus–CRM (green). In
some nuclei with a low level of
Venus–CRM, a single bright
band corresponding to a chro-
mosome section is visible
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or crm mutant larvae shows that it is strongly reduced in
crm mutants (Fig. 4b). In addition to a specific role of
CRM on the expression of H1, the linker histone, this
reveals also a previously unknown role of crm in the
activation of gene expression.
CRM cooperates with TRF2 in the activation of H1 and in
the development of the wing The specific requirement of
crm for H1 expression correlates well with the observation
that the histone H1 gene is regulated differently than the
other core histones; the genes encoding core histones
require the TBP for expression, whereas H1 requires the
TRF2 (Isogai et al. 2007). Thus, TRF2 and CRM appear to
be specifically required for the expression of H1. As TRF2
mutants display the same wing margin phenotype seen in
crm mutants, we decided to test if they function together,
using the Drosophila wing as an assay (Kopytova et al.
2006). We analyzed the wing phenotypes of crm-trf2
double mutants using the hypomorphic allele TRF2G0039
(Bashirullah et al. 2007). TRF2G0039 wings are smaller but
have intact wing margin. The crm mutants show small
wings with a few notches. We observe a strong increase in
the wing margin notching in crm-trf2 double mutants,
indicating a strong genetic interaction (Fig. 5a–d). To
confirm the genetic interaction between CRM and TRF2,
we performed a reciprocal analysis. We used transgenic
flies expressing dominant-negative forms of CRM in which
specific conserved domains are deleted (Gibert et al. 2011).
One of our mutants (deletion of amino acids 736–821)
behaves as a strong dominant mutant. Its ubiquitous
expression in a wild-type background using tub-gal4 causes
larval lethality before metamorphosis. When we drove its
expression in the wing disc using bi-gal4 we obtained flies
with a strong wing growth defect (Fig. 5f). This phenotype
is dose sensitive as two doses of the UAS-crm-delV leads to
extremely small wings (Fig. 5f, asterisks). The co-
expression of an mCherry-Trf2 fusion (see below) with
the dominant mutant cancels the effect of the dominant
mutant and rescues the wing growth (Fig. 5h). This
observation suggests that expression of mCherry-Trf2
titrates the dominant mutant or compensates for titration
of Trf2 by the dominant mutant. We, therefore, tested
whether CRM and TRF2 could be co-immunoprecipitated.
Indeed, co-immunoprecipitation experiments using extracts
from embryos expressing Venus–CRM demonstrate that
CRM and TRF2 exist in vivo in a complex (Fig. 6).
Interestingly, whereas we observe two bands for TRF2 in
the input, the upper one is much more abundant than the
lower one in the co-immunoprecipitation, suggesting that
a modified form of TRF2 interacts with CRM. In
conclusion, our findings show that CRM and TRF2
cooperate closely in the activation of H1 and potentially
other targets.
CRM and TRF2 co-localize on His-C but are not strictly
required for the recruitment of one another To further
substantiate the interaction between CRM and TRF2, we
have generated a fluorescent fusion of TRF2. Figure 7 (a, b,
c and d) reveals in vivo co-localization of EBFP2-CRM,
mCherry–TRF2, and DLSM11–Venus in salivary gland
nuclei, indicating that CRM and TRF2 are present
simultaneously on His-C. On squashed salivary gland,
polytene chromosomes Venus–CRM and TRF2 co-localize
on His-C, which is their major binding site (Fig. 7e–h). We
Fig. 2 CRM is present on the
histone locus. In vivo imaging
of Venus–CRM (green; a, c) in
combination with mCherry–HP1
(red; b, c) and mCherry–CRM
(red; d, f) in combination with
the histone locus marker
DLsm11–Venus (green; e, f).
The Venus–CRM bright band is
located close to the chromocen-
ter (c) and the mCherry–CRM
bright band co-localizes with the
histone locus (d–e)
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Fig. 3 Co-immunostaining for
CRM (green) and PCNA (red)
on salivary gland polytene
chromosomes. The different
phases of the replication cycle
can be identified thanks to
PCNA pattern: G1 phase (left),
early S-phase (middle), late
S-phase (right)
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analyzed whether CRM and TRF2 are required for the
recruitment of one another on His-C in salivary glands. We
found that CRM can be detected on His-C in Trf2
hypomorphic mutants and reciprocally, TRF2 can be
detected on His-C in crm null mutants (Fig. 8). Therefore,
they are not particularly limiting for the recruitment of each
other on His-C and seem to be able to bind His-C
independently. However, we observed that in Trf2 mutants,
a higher level of CRM is detected on the chromocenter
(Fig. 8g–i). Furthermore, we observed that chromosome
condensation is altered in crm mutants, as previously
reported in salivary glands of H1 RNAi larvae (Siriaco et
al. 2009).
CRM role on His-C is independent of PcG factors In order
to test whether CRM role on His-C could be dependent on
PcG proteins we stained salivary gland polytene chromo-
somes with antibodies against CRM and posterior sex comb
(PSC), a well-characterized component of the Polycomb
complex PRC1. We observed few co-localizations on
chromosome arms, but PSC clearly does not co-localize
with CRM on His-C (Fig. 9). In agreement with this, no
binding of PcG proteins on His-C have been reported until
now (Schwartz et al. 2006).
Discussion
Yamamoto et al. (1997) characterized crm as a repressive
factor, dynamically regulated during the cell cycle, and
involved in position effect variegation and Polycomb
silencing. The belonging to the PcG gene family is based
on the appearance of additional sex comb on the posterior
legs of crm mutants, as well as on the genetic interactions
(enhancement) with mutations in individual genes of the
PcG family. Furthermore, crm mutation also behaves as
suppressor of the variegated eye phenotype caused by the
relocation of the white+ next to heterochromatin (wm4h).
Using fluorescent fusions we confirm that CRM is
dynamically regulated during the cell cycle. By co-
staining with PCNA, we identify early S-phase as the peak
of CRM production where CRM is widely present on
chromosomes at many regions, co-localizing extensively
with PCNA. In the late S-phase, it is present at much fewer
sites but can be detected on the chromocenter where it co-
localizes with PCNA. Together with its requirements for
chromatin regulation (in particular centromeric heterochro-
matin), co-localization of CRM and PCNA suggests a role
of CRM in the transmission of epigenetic information
during replication, as previously suggested by Yamamoto
et al. (1997).
We report here the previously unknown localization of
CRM on the Histone cluster and its involvement in the
activation of the Histone 1 gene. No PcG protein has been
reported to bind His-C and we clearly do not detect PSC, a
member of the PcG complex PRC1, on His-C. It is
therefore likely to correspond to a role of crm independent
of traditional PcG proteins. Our observation that crm is
involved in the activation of gene transcription contradicts
heterochromatic gene. CRM could be a general activator
required for the activation of particular PcG and Su(var)
genes. In agreement with this interpretation, mutations in
H1 have been shown to act as suppressors of PEV (Lu et al.
2009). The strong underexpression of H1 in crm mutants
could thus be responsible for the phenotypes observed in
crm mutants. This is likely the case for chromosome
larvae (Siriaco et al. 2009). However, downregulation of
Fig. 4 Expression of H1 is altered in crm mutants. a Real-time PCR
analysis of the expression levels of the five histone genes in salivary
glands of wild-type (OrR) and crm mutant (crm32 or crm7) third instar
larvae. Expression of the histone genes was normalized with the
control genes EF1g, RP49, TBP, GapdHI, and RNApolII; ±1 standard
deviations are represented. The expression level of H1 is reduced 30
to 40 times in crm mutants compared to WT (p<0.05). No significant
difference is observed for the genes encoding the core histones. b
Western blot analysis of H1 protein level in salivary glands of WT
(OrR) or crm mutant larvae (crm7 or crm32)
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with any Polycomb phenotypes as Trf2 pharates do not
have ectopic sex combs. A second possibility is that crm
condensation defects, which are observed in H1 RNAi
H1 does not explain all our observations. For example, the
strong reduction of H1 in Trf2 mutants is not associated
the earlier classification of the crm gene as a PcG/
plays distinct roles in both activation and repressive
processes, probably depending on the partners with which
it associates. This is typical of members of the ETP group
such as the GAGA factor (Gildea et al. 2000). Interactions
with particular factors such as TRF2 might condition the
specific requirement of crm for particular targets. This does
not seem to be the case for His-C, as CRM can be detected
on His-C in TRF2 mutants. Therefore, CRM and TRF2
may not be the components of a stable complex. Their co-
immunoprecipitation likely reflects their common recruit-
ment to His-C (and potentially other genomic loci).
However, we observed more CRM on the chromocenter
in Trf2 mutants which suggests that TRF2, at least
indirectly, controls some aspects of CRM chromosomal
localization. CRM is one of the few factors known to be
involved with TRF2 in gene activation. Indeed, although
TRF2 is an essential factor, component of core promoter
recognition complexes, and involved in the regulation of
more than 1,000 genes in S2 cells, very few of its
cofactors are known (Isogai et al. 2007). The best
characterized are TFIIA and TFIIB, components of the
basal transcription machinery (Rabenstein et al. 1999).
Interestingly, the mammalian protein TIP2 was shown
recently to physically interact with TRF2 and Polycomb
proteins (Pitulescu et al. 2009), showing, like our findings,
that particular factors can have connection with both TRF2
and Polycomb silencing.
Fig. 6 Venus–CRM and TRF2 co-immunoprecipitate in embryonic
extracts. CO-IP with anti-GFP beads and WT embryonic extracts
(without Venus–CRM) or with empty beads and Venus–CRM
embryonic extracts were used as controls
Fig. 5 a–d crm and TRF2 in-
teract genetically for the devel-
opment of the wing margin. In
contrast to wild-type flies (a)
crm32 mutants have smaller
wings with notches (asterisks)
(b). TRF2G0039 hypomorphic
mutants die during metamor-
phosis or as pharate adults.
Wings dissected out of the pupal
case are smaller but look mostly
normal, with intact wing mar-
gins (c). In contrast, double
mutants crm32 TRF2G0039 have a
larger region of the wing margin
missing (asterisks) (d). All pic-
tures were taken at the same
magnification. The line repre-
sents the same region of the
wing for easier comparison.
e–h The co-expression of TRF2
suppresses crm-dominant mu-
tant phenotypes. Expression of a
crm deletion mutant in the wing
disc using the bi-Gal4 driver
leads to a strong and dose
sensitive growth defect (f one
dose, small frame (asterisk), two
doses of the dominant mutant
transgene). Expression of
mCherry-Trf2 with the same
driver has no effect on the wing
growth (g), but in combination
with the crm-dominant mutant it
rescues the growth phenotype
(h). Note that bi-Gal4 is a
hypomorphic allele of bi
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Methods
Construction of transgenic flies expressing fluorescent
fusions
We amplified the coding sequences of Venus (Nagai et al.
2002), mCherry (Shaner et al. 2004), and EBFP2 (Ai et al.
2007) by PCR using primers with floating restrictions sites
(5′, EcoRI; 3′, BglII). The PCR products were cloned in
pGEM-T Easy (Promega) and sequenced. The coding
sequence of the fluorochrome was then cut by EcoRI and
BglII and cloned into the pUASTattB vector (Bischof et al.
2007) opened with EcoRI and BglII to constitute respec-
tively pUASTVenus-attB, pUASTmCherry-attB, and
pUASTEBFP2attB. We amplified the coding sequence of
CRM, HP1, and TRF2 by PCR using primers with the
floating restriction sites. TRF2 clones were made using the
short isoform (Kopytova et al. 2006). The PCR products
were cloned in pGEM-T Easy. The coding sequence of
CRM, HP1, and TRF2 were cut by the appropriate enzymes
and cloned into PUASTVenus(mCherry or EBFP2)attB
opened with BglII and XbaI to construct in-frame fusions.
The constructs were integrated into the landing sites 22A
(Venus–CRM, mCherry–HP1), 58A (mCherry–TRF2), or
51D (EBFP2–CRM) on the second chromosome by
injection of embryos with a source of PhiC31 integrase on
the X chromosome (Bischof et al. 2007).
Fly cultures
Fly crosses were done at 25°C using balancer chromo-
somes and standard agar–corn medium. The crm7 and
trf2G0039 were previously described (Bashirullah et al.
2007; Yamamoto et al. 1997). The crm32 allele was
generated by imperfect excision of the P element inserted
in the stock crmEY05302 (Flybase).
Fluorescence microscopy
Observation and image capture were made on an Axioplan
microscope (Zeiss) with an Optronix camera and Magna-
Fire software. We used the leaky driver HS::GAL4, without
heat shock, to induce a moderate expression of the
fluorescent constructs in the salivary glands. Salivary
glands were observed in 0.7% NaCl.
Expression analysis
The expression of each of the histone genes was measured
by real-time PCR in wild-type (OregonR) and mutant
(crm32 and crm7) salivary glands. We used three biological
samples per condition and three technical replicates per
biological sample. Thirty pairs of salivary glands were
Fig. 7 CRM and TRF2 co-localize in vivo on His-C. In vivo imagining
of the fluorescent fusion protein EBFP2-CRM (a), dLsm11–Venus (b),
and mCherry–TRF2 (c) in a salivary gland nucleus. Venus–CRM and
TRF2 co-localize on His-C on squashed polytene chromosomes.
Staining with a mouse anti-GFP antibody (e, green) and a rabbit anti-
TRF2 antibody (f, red) on squashed salivary gland polytene chromo-
somes from larvae expressing Venus–CRM, blue (g, h) Dapi. The His-C
is the strongest binding site of both proteins
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dissected for each biological replicate. cDNA were synthe-
sized using Trizol extracted total RNAs. The genes EF1g,
RP49, TBP, GapdH1, and RNApolII were used as controls
to normalize the data.
The primers used were the following:
Histone H1 (Forward: CCCAAAAGTTAGCGC
CATTC; reverse: TGACCACGGCCGATTTTAAG)
Histone 2A (Forward: GCAAAGTCCCGCT
CAAACC; reverse:CCGGAGCAAACGGTGAATAC)
Histone 2B (Forward: ACAAGCGCTCGACCAT
CAC; reverse:CCAACTCTCCAGGCAAAAGC)
Histone 3 (Forward: AAGCCCCACCGCTATCG;
reverse: CTCTTTTGGTAGCGACGAATTTC)
Histone 4 (Forward: GAGGCAAAGGCTTGG
GAAAG; reverse: TGGATGTTATCACGCAG
CACTT)






Gapdh1 ( F o rwa r d : ATTTCGCTGAACGA
TAAGTTCGT; reverse: CGATGACGCGGTTG
GAGTA)
pol II (Forward: CCTTCAGGAGTACGGCTAT
CATCT; reverse:CCAGGAAGACCTGAGCAT
TAATCT)
Immunostaining on squashed polytene chromosomes
Immunostaining on squashed polytene chromosomes from
WT (y w) or UAS-VenusCRM; HS::GAL4 larvae were
done as previously described (Gibert et al. 2007). The
squashes of polytene chromosomes were made with a
slightly different protocol (Spierer et al. 2008).
Fig. 8 CRM and TRF2 can
bind independently on His-C.
Immunostaining for CRM or
TRF2 in WT or crm or Trf2
mutants. CRM and TRF2 can be
detected on S in the absence of
one another. We detect more
CRM on the chromocenter in
Trf2 mutants (g, i)
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We used the following antibodies: monoclonal mouse anti-
GFP (3E6, Qbiogen); polyclonal rabbit anti-GFP (ab6556,
abcam); polyclonal Rabbit anti-CRM (Yamamoto et al. 1997);
polyconal rabbit anti-TRF2 (Rabenstein et al. 1999); mouse
monclonal anti-PSC (Hybridoma bank); and mouse mono-
clonal anti-PCNA (PC10, Santa Cruz Biotechnology).
Co-immunoprecipitation and Western blots
Immunoprecipitations of Venus–CRM were done as de-
scribed previously (Rozenblatt-Rosen et al. 1998), with
minor modifications using dechorionated embryos express-
ing Venus–CRM driven by tub::GAL4. The composition of
the immunoprecipitation (IP) buffer was 50 mM Tris,
pH 8.0, 200 mM NaCl, 0.1 mM EDTA, and 0.1% NP40.
One tablet of complete protease inhibitor (Roche) was
added per 10 ml of IP buffer. The protein A agarose beads
were purchased from PIERCE. The anti-GFP antibody used
for the IP was the mouse monoclonal antibody 3E6
(QBiogen). Western blots were performed using rabbit
polyclonal anti-TRF2 (Rabenstein et al. 1999). As negative
controls, we used extracts from wild-type embryos (without
Venus–CRM) or agarose beads without antibodies or with
anti-GST antibodies.
For the H1 western blot we used rabbit antibody against
Drosophila H1 (Active Motif, catalog number 39575) and
mouse monoclonal antibody against alpha-tubulin (Sigma,
T9026) as loading control. Twenty-five pairs of salivary
glands for each genotype were dissected and homogenized
in 40 μl of loading buffer. Ten microliters were used for the
Western blot.
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